Navigation Links
PRI Condemns PEPFAR Amendments
Date:2/6/2008

FRONT ROYAL, Va., Feb. 6 /PRNewswire-USNewswire/ --- Population Research Institute has joined other pro-life groups in condemning amendments to the President's Emergency Plan for AIDS Relief (PEPFAR).

PEPFAR is up for reauthorization on Thursday, February 14, 2008, in the House Foreign Affairs Committee. According to PRI's president Steven Mosher, the preliminary drafts have been compromised by amendments that put the money directly in the hands of known population controllers.

"It would be better if President Bush had never proposed PEPFAR, than to have 50 billion dollars hijacked by abortion-promoting, chastity-mocking, anti-people groups like IPPF, UNFPA, and the Chinese government," said Mosher. "If the amendments promoted by the Democrat majority are passed, a veto will be the President's only option."

These amendments include "family planning" language that does not exclude abortion, lifting important abortion restrictions imposed by the Mexico City Policy, a removal of the anti-prostitution pledge, and a full integration of family planning services with HIV aid services.

PRI urges pro-lifers everywhere to contact the members of the House Foreign Affairs Committee and encourage them to vote against this bill. Information about this committee can be found at http://www.foreignaffairs.house.gov.

The Population Research Institute (PRI) was founded in 1989 by Fr. Paul Marx, OSB, PhD and is dedicated to: (1) ending human rights abuses committed in the name of "family planning," (2) opposing outdated social and economic paradigms premised on the myth of overpopulation, (3) informing the public about the social and economic benefits of moderate population growth, and (4) promoting pro-natal and pro-family attitudes and policies worldwide.


'/>"/>
SOURCE Population Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Catholic Health Association Condemns Denial of Health Insurance for Children
2. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
3. China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
Breaking Medicine Technology: